Other Analytical, Diagnostic and Therapeutic Techniques and Equipment Commons^™

Using Digital Assessment Technology To Detect Neuropsychological Problems In Primary Care Settings, David J Libon, Emily Frances Matusz, Stephanie Cosentino, Catherine C Price, Rod Swenson, Meagan Vermeulen, Terrie Beth Ginsberg, Adaora Obiageli Okoli-Umeweni, Leonard Powell, Robert Nagele, Sean Tobyne, Joyce Rios Gomes-Osman, Alvaro Pascual-Leone

Rowan-Virtua School of Osteopathic Medicine Faculty Scholarship

INTRODUCTION: Screening for neurocognitive impairment and psychological distress in ambulatory primary and specialty care medical settings is an increasing necessity. The Core Cognitive Evaluation™ (CCE) is administered/scored using an iPad, requires approximately 8 min, assesses 3- word free recall and clock drawing to command and copy, asks questions about lifestyle and health, and queries for psychological distress. This information is linked with patients' self- reported concerns about memory and their cardiovascular risks.

METHODS: A total of 199 ambulatory patients were screened with the CCE as part of their routine medical care. The CCE provides several summary indices, and scores on …

Racial Differences In The Effect Of Apoe-Ε4 Genotypes On Trail Making Test Part B In Alzheimer’S Disease, Kaysie N. Ozuna, Annu Katithara, Chun Xu

Research Symposium

The trail making test part B (TMT-B) is used to evaluate executive functions in order to better understand the progression of Alzheimer’s disease (AD). The objective of this study is to better understand the association of apolipoprotein E epsilon 4 (APOE-ε4) genotypes on the TMT-B scores in those with Alzheimer’s disease, specifically in the Hispanic population. This study used data from the Alzheimer's Disease Neuroimaging Initiative (ADNI). In total there were 482 participants with AD, 503 with cognitive normal (CN), 1,293 with MCI at baseline and a follow-up after four years. In this study the longitudinal effect of …

Development Of Gaussian Learning Algorithms For Early Detection Of Alzheimer's Disease, Chen Fang

FIU Electronic Theses and Dissertations

Alzheimer’s disease (AD) is the most common form of dementia affecting 10% of the population over the age of 65 and the growing costs in managing AD are estimated to be $259 billion, according to data reported in the 2017 by the Alzheimer's Association. Moreover, with cognitive decline, daily life of the affected persons and their families are severely impacted. Taking advantage of the diagnosis of AD and its prodromal stage of mild cognitive impairment (MCI), an early treatment may help patients preserve the quality of life and slow the progression of the disease, even though the underlying disease cannot …